Secretory <scp>IgA</scp> Is a Key Marker Among Gut Barrier Dysfunction‐Related Immunoglobulins Predicting Outcomes in <scp>ACLF</scp>
Enhanced BT-triggered immune activation is indicated by increased total-IgA levels in association with the occurrence of target-specific IgA antibodies. Serum sIgA is a promising marker of gut barrier failure and 90-day mortality in ACLF.
Authors
- Tamás Dinya
- Jonel Trebicka (ORCID: https://orcid.org/0000-0002-7028-3881)
- Dávid Tornai (ORCID: https://orcid.org/0000-0002-1335-5498)
- Patrícia Kováts (ORCID: https://orcid.org/0000-0003-0975-7168)
- Minneke J. Coenraad (ORCID: https://orcid.org/0000-0002-3434-4421)
- Boglárka Balogh (ORCID: https://orcid.org/0000-0002-5670-1063)
- Wim Laleman (ORCID: https://orcid.org/0000-0002-0842-7813)
- Péter Antal‐Szalmás (ORCID: https://orcid.org/0000-0002-9246-726X)
- Anikó Csillag
- Mária Papp (ORCID: https://orcid.org/0000-0003-3662-4010)
- Zsuzsanna Vitális (ORCID: https://orcid.org/0000-0001-8198-5312)
- István Tornai (ORCID: https://orcid.org/0000-0002-8163-101X)
Institutions
- University of Debrecen (HU)
- University of Münster (DE)
- Leiden University Medical Center (NL)
- European Foundation for the Study of Chronic Liver Failure (ES)
- KU Leuven (BE)
Publication Details
- Journal
- Liver International
- Published
- 2025-09-13
- DOI
- https://doi.org/10.1111/liv.70350
- Citations
- 2
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.64